Chinese patent drug for treating cirrhosis

Abstract

The invention discloses a prepared traditional Chinese medicinal preparation for treating cirrhosis characterized in that it is prepared from the following raw materials (by weight proportion): astragalus root 10-20 part, white atractylodes rhizome 4-15 parts, poria cocos wolf 4-15 parts, nutgrass flatsedge rhizome 4-15 parts, prepared dark Japanese plum 4-15 parts, pawpaw 4-15 parts, zedoary 4-15 parts, capilary Artemisia 4-15 parts, , haw 8-16 parts, malt 4-15 parts, root of red rooted saliva 10-30 parts, turtle shell 10-30 parts and prepared licorice root 2-10 parts.

Description

Technical field: [0001] The invention relates to the technical field of Chinese patent medicines, in particular to a Chinese patent medicine for treating liver cirrhosis which uses Chinese herbal medicines as raw materials. Background technique: [0002] my country is an area with a high incidence of viral hepatitis, and there are 120 million HBV-infected people. Most of the liver cirrhosis is caused by chronic hepatitis B. The liver cirrhosis is divided into a decompensated phase and a compensated phase according to histopathology and clinical manifestations. The effective treatment of decompensated liver cirrhosis by western medicine at home and abroad is liver transplantation, but liver transplantation has few sources of liver and is expensive, and it is out of reach for ordinary people. Supportive nutrition and symptomatic treatment can only be adopted; some Chinese medicines are also used for treatment. , but the effect is not very satisfactory. Invention content: [0...

AI Technical Summary

Problems solved by technology

It mainly solves the existing problems of few liver sources, high price and unsatisfactory treatment effect of traditional Chinese medicine for liver transplantation in the treatment of decompensated liver cirrhosis.